GKCC LLC 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-27 9:36 pm Purchase | 2024-06-07 | 13G | Xilio Therapeutics, Inc. XLO | GKCC LLC | 7,000,000 15.900% | 7,000,000 (New Position) | Filing |